SYROS PHARMACEUTICALS, INC. Long-term Debt, Gross
SYROS PHARMACEUTICALS, INC. had Long-term Debt, Gross of $40.00 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentCarryingAmount · last filed 2024-10-31
- 2024-09-30: Long-term Debt, Gross $40.00M.
- 2024-06-30: Long-term Debt, Gross $40.00M.
- 2024-03-31: Long-term Debt, Gross $40.00M.
- 2023-12-31: Long-term Debt, Gross $40.00M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2024-09-30 | $40.00M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $40.00M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $40.00M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $40.00M 10-K · filed 2024-03-27 |
| 2023-09-30 | $40.00M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $40.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $40.00M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $40.00M 10-K · filed 2023-03-02 |
| 2022-09-30 | $40.00M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $40.00M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $40.00M 10-Q · filed 2022-05-16 |